Balanced news tone
News Sentiment
NOV sentiment intelligence
Novo Nordisk A/S news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
49
Balanced news tone
13 relevant articles
News tone and price action are not far from neutral.
86/100 classification confidence.
directly relevant articles
high-authority source matches
+2.0% over one week, +1.2% over four weeks, trend active, and below fair value.
Novo Nordisk Stock - Deutsche Bank reiterates Hold rating
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
86/100 classification
One-week reaction
2.0%
Price confirming higher
Trend fit
Trend active
1.2% over four weeks
Fair value
-20.2%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
2
Neutral
10
Negative
1
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
AD HOC NEWS
Direct company coverage
Novo Nordisk Stock - Deutsche Bank reiterates Hold rating
- Tone
- Neutral 50/100
- Event
- Analyst action
- Published
- 19 Jun 2026 19:43
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Novo Nordisk A/S stock (DK0062498333): Danish pharma heavyweight steadies after recent pullback
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Novo Nordisk A/S stock (DK0060534915): buyback update and steady trading after Q1 2026 results
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 01 Jun 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Novo Nordisk A/ S stock (DK0062498333): Valuation focus after Deutsche Bank reiteration
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 May 2026 07:00
- Source
- AD HOC NEWS
AD HOC NEWS
Direct company coverage
Novo Nordisk A/S stock (DK0062498333): new cardiometabolic data in focus after sharp pullback
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 28 May 2026 07:00
- Source
- AD HOC NEWS
news.financial
Direct company coverage
Caution with BioNTech! Novo Nordisk Accelerates! Buying Opportunity in Vidac Pharma Stock?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 May 2026 05:37
- Source
- news.financial
Seeking Alpha
Direct company coverage
Novo Nordisk: A Generational Buying Opportunity Ahead Of Q1 Earnings (Preview) (NYSE:NVO)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 04 May 2026 07:00
- Source
- Seeking Alpha
Barchart.com
Direct company coverage
Novo Nordisk Just Announced Wegovy Subscriptions. Does That Make NVO Stock a Buy?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 02 Apr 2026 07:00
- Source
- Barchart.com
Bloomberg.com
Direct company coverage
European Stocks Post Fifth Weekly Advance; Novo Nordisk Rises
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 16 Jan 2026 08:00
- Source
- Bloomberg.com
Barchart.com
Direct company coverage
As the FDA Approves a Wegovy Pill, Should You Buy, Sell, or Hold Novo Nordisk Stock?
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Dec 2025 08:00
- Source
- Barchart.com
Reuters
Direct company coverage
Novo Nordisk shares fall as top investor drives board overhaul
- Tone
- Negative 22/100
- Event
- Market update
- Published
- 22 Oct 2025 07:00
- Source
- Reuters
Market source
Direct company coverage
Novo Nordisk Reclaims Top Spot in Europe by Market Value
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 17 Jun 2025 07:00
- Source
- Market source
Market source
Direct company coverage
Is Novo Nordisk (NVO) the Best ADR Stock to Buy According to Hedge Funds?
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 28 Mar 2025 07:00
- Source
- Market source